198 related articles for article (PubMed ID: 27628328)
1. EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.
Navazio AS; Rizzolo P; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Tommasi S; Palli D; Ottini L
Breast Cancer Res Treat; 2016 Nov; 160(1):181-186. PubMed ID: 27628328
[TBL] [Abstract][Full Text] [Related]
2. Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers.
Rizzolo P; Navazio AS; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Scarnò M; Tommasi S; Palli D; Ottini L
Oncotarget; 2016 Nov; 7(45):74097-74106. PubMed ID: 27765917
[TBL] [Abstract][Full Text] [Related]
3. EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
Bane AL; Mulligan AM; Pinnaduwage D; O'Malley FP; Andrulis IL
Breast Cancer Res Treat; 2011 Jun; 127(3):831-9. PubMed ID: 21327470
[TBL] [Abstract][Full Text] [Related]
4. Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.
Brown LA; Johnson K; Leung S; Bismar TA; Benítez J; Foulkes WD; Huntsman DG
Breast Cancer Res Treat; 2010 Jun; 121(2):347-54. PubMed ID: 19636701
[TBL] [Abstract][Full Text] [Related]
5. BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.
Ottini L; Rizzolo P; Zanna I; Falchetti M; Masala G; Ceccarelli K; Vezzosi V; Gulino A; Giannini G; Bianchi S; Sera F; Palli D
Breast Cancer Res Treat; 2009 Aug; 116(3):577-86. PubMed ID: 18819001
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
[TBL] [Abstract][Full Text] [Related]
7. BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.
Falchetti M; Lupi R; Rizzolo P; Ceccarelli K; Zanna I; Calò V; Tommasi S; Masala G; Paradiso A; Gulino A; Giannini G; Russo A; Palli D; Ottini L
Breast Cancer Res Treat; 2008 Jul; 110(1):161-7. PubMed ID: 17661168
[TBL] [Abstract][Full Text] [Related]
8. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
[TBL] [Abstract][Full Text] [Related]
9. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
Deb S; Jene N; ; Fox SB
BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
[TBL] [Abstract][Full Text] [Related]
12. Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations.
George J; Alsop K; Etemadmoghadam D; Hondow H; Mikeska T; Dobrovic A; deFazio A; ; Smyth GK; Levine DA; Mitchell G; Bowtell DD
Clin Cancer Res; 2013 Jul; 19(13):3474-84. PubMed ID: 23633455
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer.
Deb S; Do H; Byrne D; Jene N; ; Dobrovic A; Fox SB
Breast Cancer Res; 2013; 15(4):R69. PubMed ID: 23971979
[TBL] [Abstract][Full Text] [Related]
14. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
Pritzlaff M; Summerour P; McFarland R; Li S; Reineke P; Dolinsky JS; Goldgar DE; Shimelis H; Couch FJ; Chao EC; LaDuca H
Breast Cancer Res Treat; 2017 Feb; 161(3):575-586. PubMed ID: 28008555
[TBL] [Abstract][Full Text] [Related]
15. Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer.
Biesma HD; Schouten PC; Lacle MM; Sanders J; Brugman W; Kerkhoven R; Mandjes I; van der Groep P; van Diest PJ; Linn SC
Genes Chromosomes Cancer; 2015 Dec; 54(12):734-44. PubMed ID: 26355282
[TBL] [Abstract][Full Text] [Related]
16. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
[TBL] [Abstract][Full Text] [Related]
17. BRCA2 gene mutations in Slovenian male breast cancer patients.
Besic N; Cernivc B; de Grève J; Lokar K; Krajc M; Novakovic S; Zgajnar J; Teugels E
Genet Test; 2008 Jun; 12(2):203-9. PubMed ID: 18439106
[TBL] [Abstract][Full Text] [Related]
18. Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
Rodriguez C; Hughes-Davies L; Vallès H; Orsetti B; Cuny M; Ursule L; Kouzarides T; Theillet C
Clin Cancer Res; 2004 Sep; 10(17):5785-91. PubMed ID: 15355907
[TBL] [Abstract][Full Text] [Related]
19. Expression of EMSY gene in sporadic ovarian cancer.
Altinisik J; Karateke A; Coksuer H; Ulutin T; Buyru N
Mol Biol Rep; 2011 Jan; 38(1):359-63. PubMed ID: 20349280
[TBL] [Abstract][Full Text] [Related]
20. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Silvestri V; Barrowdale D; Mulligan AM; Neuhausen SL; Fox S; Karlan BY; Mitchell G; James P; Thull DL; Zorn KK; Carter NJ; Nathanson KL; Domchek SM; Rebbeck TR; Ramus SJ; Nussbaum RL; Olopade OI; Rantala J; Yoon SY; Caligo MA; Spugnesi L; Bojesen A; Pedersen IS; Thomassen M; Jensen UB; Toland AE; Senter L; Andrulis IL; Glendon G; Hulick PJ; Imyanitov EN; Greene MH; Mai PL; Singer CF; Rappaport-Fuerhauser C; Kramer G; Vijai J; Offit K; Robson M; Lincoln A; Jacobs L; Machackova E; Foretova L; Navratilova M; Vasickova P; Couch FJ; Hallberg E; Ruddy KJ; Sharma P; Kim SW; ; Teixeira MR; Pinto P; Montagna M; Matricardi L; Arason A; Johannsson OT; Barkardottir RB; Jakubowska A; Lubinski J; Izquierdo A; Pujana MA; Balmaña J; Diez O; Ivady G; Papp J; Olah E; Kwong A; ; Nevanlinna H; Aittomäki K; Perez Segura P; Caldes T; Van Maerken T; Poppe B; Claes KB; Isaacs C; Elan C; Lasset C; Stoppa-Lyonnet D; Barjhoux L; Belotti M; Meindl A; Gehrig A; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Kast K; Arnold N; Varon-Mateeva R; Wand D; Godwin AK; Evans DG; Frost D; Perkins J; Adlard J; Izatt L; Platte R; Eeles R; Ellis S; ; Hamann U; Garber J; Fostira F; Fountzilas G; Pasini B; Giannini G; Rizzolo P; Russo A; Cortesi L; Papi L; Varesco L; Palli D; Zanna I; Savarese A; Radice P; Manoukian S; Peissel B; Barile M; Bonanni B; Viel A; Pensotti V; Tommasi S; Peterlongo P; Weitzel JN; Osorio A; Benitez J; McGuffog L; Healey S; Gerdes AM; Ejlertsen B; Hansen TV; Steele L; Ding YC; Tung N; Janavicius R; Goldgar DE; Buys SS; Daly MB; Bane A; Terry MB; John EM; Southey M; Easton DF; Chenevix-Trench G; Antoniou AC; Ottini L
Breast Cancer Res; 2016 Feb; 18(1):15. PubMed ID: 26857456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
